The rationale for neoadjuvant radiation therapy in malignant pleural mesothelioma: how smart is SMART?

gan Cho, B. C. John
Cyhoeddwyd yn Ann Transl Med (2017)

Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors

gan Westover, D, Zugazagoitia, J, Cho, B C, Lovly, C M, Paz-Ares, L
Cyhoeddwyd yn Ann Oncol (2018)

Outcomes of accelerated hypofractionated radiotherapy in stage i non-small-cell lung cancer

gan Yung, T., Giuliani, M.E., Le, L.W., Sun, A., Cho, B.C.J., Bezjak, A., Brade, A., Hope, A.J.
Cyhoeddwyd 2012

Frequent disruption of the Nf1 gene by a novel murine AIDS virus-related provirus in BXH-2 murine myeloid lymphomas.

gan Cho, B C, Shaughnessy, J D, Largaespada, D A, Bedigian, H G, Buchberg, A M, Jenkins, N A, Copeland, N G
Cyhoeddwyd 1995

A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens

gan Jeung, H-C, Rha, S Y, Cho, B C, Yoo, N C, Roh, J K, Roh, W J, Chung, H C, Ahn, J B
Cyhoeddwyd 2006

Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes on outcomes in lung stereotactic body radiotherapy

gan Giuliani, M., Sampson, L.R., Wong, O., Gay, J., Le, L.W., Cho, B.C.J., Brade, A., Sun, A., Bezjak, A., Hope, A.J.
Cyhoeddwyd yn Curr Oncol (2016)

Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy

gan Kim, S-M, Kim, H, Yun, M R, Kang, H N, Pyo, K-H, Park, H J, Lee, J M, Choi, H M, Ellinghaus, P, Ocker, M, Paik, S, Kim, H R, Cho, B C
Cyhoeddwyd yn Oncogenesis (2016)

Clinical role of a new prognostic score using platelet-to-lymphocyte ratio in patients with malignant pleural mesothelioma undergoing extrapleural pneumonectomy

gan Tagawa, Tetsuzo, Anraku, Masaki, Morodomi, Yosuke, Takenaka, Tomoyoshi, Okamoto, Tatsuro, Takenoyama, Mitsuhiro, Ichinose, Yukito, Maehara, Yoshihiko, Cho, B. C. John, Feld, Ronald, Tsao, Ming-Sound, Leighl, Natasha, Bezjak, Andrea, Keshavjee, Shaf, de Perrot, Marc
Cyhoeddwyd yn J Thorac Dis (2015)

Dabrafenib in BRAF V600E–Mutant Advanced Non-Small Cell Lung Cancer: an Open-label, Single arm, Multicenter, Phase 2 Trial

gan Planchard, David, Kim, Tae Min, Mazieres, Julien, Quoix, Elisabeth, Riely, Gregory, Barlesi, Fabrice, Souquet, Pierre-John, Smit, Egbert F., Groen, Harry J. M., Kelly, Ronan J., Cho, B. C., Socinski, Mark A., Pandite, Lini, Nase, Christine, Ma, Bo, D’Amelio, Anthony, Mookerjee, Bijoyesh, Curtis, C. Martin, Johnson, Bruce E.
Cyhoeddwyd yn Lancet Oncol (2016)

A Comparison of Hypofractionated and Twice-Daily Thoracic Irradiation in Limited-Stage Small-Cell Lung Cancer: An Overlap-Weighted Analysis

gan Yan, Michael, Sigurdson, Samantha, Greifer, Noah, Kennedy, Thomas A. C., Toh, Tzen S., Lindsay, Patricia E., Weiss, Jessica, Hueniken, Katrina, Yeung, Christy, Sugumar, Vijithan, Sun, Alexander, Bezjak, Andrea, Cho, B. C. John, Raman, Srinivas, Hope, Andrew J., Giuliani, Meredith E., Stuart, Elizabeth A., Owen, Timothy, Ashworth, Allison, Robinson, Andrew, de Moraes, Fabio Ynoe, Liu, Geoffrey, Lok, Benjamin H.
Cyhoeddwyd yn Cancers (Basel) (2021)